Loading...

Study partners should be required in preclinical Alzheimer’s disease trials

BACKGROUND: In an effort to intervene earlier in Alzheimer’s disease (AD), clinical trials are testing promising candidate therapies in preclinical disease. Preclinical AD trial participants are cognitively normal, functionally independent, and autonomous decision-makers. Yet, like AD dementia trial...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimers Res Ther
Main Authors: Grill, Joshua D., Karlawish, Jason
Format: Artigo
Language:Inglês
Published: BioMed Central 2017
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5719524/
https://ncbi.nlm.nih.gov/pubmed/29212555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0327-x
Tags: Add Tag
No Tags, Be the first to tag this record!